FDA Approved: LACOSAMIDE — Original Application (MSN LABORATORIES PRIVATE LIMITED)

View source ↗

Summary

FDA approved MSN Laboratories' original application for lacosamide as a generic anticonvulsant under an ANDA, expanding access to lacosamide products.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)